Cargando…

Netarsudil as an Adjunctive Therapy: Efficacy and Factors Contributing to a Favorable IOP-Lowering Effect

PURPOSE: The aim of the study is to assess netarsudil's intraocular pressure (IOP)-lowering potential when prescribed as an adjunctive agent, to examine the effect of baseline IOP on patients' response to netarsudil, and to explore patients' characteristics predictive of pronounced re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samuel, Sandy, El Helwe, Hani, Neeson, Cameron E., Hall, Nathan, Meshkin, Ryan Sameen, Odishelidze, Nino, Ye, Rebecca, Chang, Ta C., Solá-Del Valle, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822751/ https://www.ncbi.nlm.nih.gov/pubmed/36620524 http://dx.doi.org/10.1155/2022/6925027

Ejemplares similares

Transscleral vs endoscopic cyclophotocoagulation: safety and efficacy when combined with phacoemulsification
por: Nirappel, Abraham, et al.
Publicado: (2023)

Netarsudil-associated reticular corneal epithelial edema
por: Tran, Jennifer A., et al.
Publicado: (2022)

Netarsudil-associated epithelial keratopathy
por: Ramakrishnan, Meera S., et al.
Publicado: (2020)

Pragmatic adjunctive usage of netarsudil: A retrospective chart review from a tertiary care center
por: Goergen, Nate S, et al.
Publicado: (2022)

Neurofilament Light Chain in Aqueous Humor as a Marker of Neurodegeneration in Glaucoma
por: Lin, Jonathan B, et al.
Publicado: (2023)

Reticular corneal epithelial edema with topical netarsudil
por: Parmar, Dipali P., et al.
Publicado: (2023)

Comparison of Netarsudil/Latanoprost Therapy with Latanoprost Monotherapy for Lowering Intraocular Pressure: A Systematic Review and Meta-analysis
por: Lee, Jong-Wook, et al.
Publicado: (2022)

Inhaled nitric oxide: an sGC-dependent IOP lowering agent
por: Lieb, Wolfgang S, et al.
Publicado: (2015)

Evaluation of the IOP-Lowering Effect of a Multi-Pressure Dial at Different Negative Pressure Settings
por: Swan, Russell J., et al.
Publicado: (2020)

Outcomes of a combination of augmented MicroPulse and limited Continuous Wave Cyclophotocoagulation in patients with refractory glaucoma
por: Gupta, Sanchay, et al.
Publicado: (2021)

Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
por: Ren, Ruiyi, et al.
Publicado: (2016)

“Rapid and reversible alteration in corneal contour and power associated with Netarsudil/Latanoprost”
por: Chung, David, et al.
Publicado: (2022)

Two pediatric cases of reticular corneal epithelial edema associated with netarsudil
por: Guzman Aparicio, Maria A., et al.
Publicado: (2022)

The IOP lowering effects of “planning” selective laser trabeculoplasty in open angle glaucoma
por: Chu, Yi-Ching, et al.
Publicado: (2022)

Remarkable Improvements After Cataract Surgery in a Presumed “End-Stage” Glaucoma Patient: A Case Report
por: El Helwe, Hani, et al.
Publicado: (2023)

Selective laser trabeculoplasty reduces mean IOP and IOP variation in normal tension glaucoma patients
por: El Mallah, Mohammed K, et al.
Publicado: (2010)

Netarsudil-Induced Corneal Flattening in a Child with Secondary Open-Angle Glaucoma
por: Ganesh, Durga, et al.
Publicado: (2022)

Detecting IOP Fluctuations in Glaucoma Patients
por: Nuyen, Brenda, et al.
Publicado: (2016)

Comparing Outcomes of Phacoemulsification and Endocyclophotocoagulation with Either Dual Blade Goniotomy (PEcK) or Two Trabecular Stents (ICE2)
por: El Helwe, Hani, et al.
Publicado: (2023)

Outcomes of Anterior Chamber, Sulcus, and Pars Plana Glaucoma Drainage Device Placement in Glaucoma Patients
por: Samuel, Sandy, et al.
Publicado: (2022)

Significance of non-intraocular pressure (IOP)-related factors particularly in normal tension glaucoma: Looking beyond IOP
por: Dinakaran, Shoruba, et al.
Publicado: (2022)

Implanted Microsensor Continuous IOP Telemetry Suggests Gaze and Eyelid Closure Effects on IOP—A Preliminary Study
por: van den Bosch, Jacqueline J. O. N., et al.
Publicado: (2021)

The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
por: Kazemi, Arash, et al.
Publicado: (2018)

Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
por: Lin, Cheng-Wen, et al.
Publicado: (2018)

Dose-dependent effects of netarsudil, a Rho-kinase inhibitor, on the distal outflow tract
por: Chen, Si, et al.
Publicado: (2020)

Effectiveness of Netarsudil as an Additional Therapy for Glaucoma in Patients Already on Maximally Tolerated Medical Therapy
por: Villegas, Natacha C, et al.
Publicado: (2021)

Real-World Clinical Impact of Netarsudil 0.02% at an Urban Safety-Net Hospital
por: Fridman, Gabrielle, et al.
Publicado: (2021)

Anterior segment optical coherence tomography features of netarsudil-associated reticular corneal edema
por: Khalili, Ashley, et al.
Publicado: (2022)

ScienceMesh for developers: how to contribute to CS3APIs and IOP
por: Gonzalez Labrador, Hugo
Publicado: (2021)

IOP, IOP Transient Impulse, Ocular Perfusion Pressure, and Mean Arterial Pressure Relationships in Nonhuman Primates Instrumented With Telemetry
por: Markert, John E., et al.
Publicado: (2018)

Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date
por: Dasso, Lily, et al.
Publicado: (2018)

Cataract Surgery combined with excimer laser trabeculotomy to lower intraocular pressure: effectiveness dependent on preoperative IOP
por: Töteberg-Harms, Marc, et al.
Publicado: (2013)

Effect of Preoperative Intraocular Pressure in Patients with and without Intolerance to Their IOP-Lowering Medication on the Outcome of Trabectome Surgery
por: Wons, Juliana, et al.
Publicado: (2021)

The Magnitude and Time Course of IOP Change in Response to Body Position Change in Nonhuman Primates Measured Using Continuous IOP Telemetry
por: Turner, Daniel C., et al.
Publicado: (2017)

A Case Report Illustrating the Postoperative Course of Descemetorhexis without Endothelial Keratoplasty with Topical Netarsudil Therapy
por: Ploysangam, Pimpiroon, et al.
Publicado: (2019)

A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension
por: Wang, Tao, et al.
Publicado: (2022)

Safety and Efficacy of Rapid Primary Phacoemulsification on Acute Primary Angle Closure with and without Preoperative IOP-Lowering Medication
por: Suzuki, Takafumi, et al.
Publicado: (2023)

A Review of Intraocular Pressure (IOP) and Axial Myopia
por: Zhang, Dongyan, et al.
Publicado: (2022)

Optic Nerve Head Gene Transcription Sequelae to a Single Elevated IOP Exposure Provides Insights Into Known Responses to Chronically Elevated IOP
por: Lozano, Diana C., et al.
Publicado: (2023)

The AIDA and the extra laser systems for excimer laser trabeculotomy proved comparable IOP lowering efficacy—12-month results
por: Hommayda, Sufian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rlugi6lkcdguqfv5vn3t88des6